Found: 10
Select item for more details and to access through your institution.
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 2, p. 398
- By:
- Publication type:
- Article
Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 321, doi. 10.1111/j.1365-2125.2011.03972.x
- By:
- Publication type:
- Article
Eltrombopag does not affect cardiac repolarization: results from a definitive QT<sub>c</sub> study in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 1, p. 24, doi. 10.1111/j.1365-2125.2010.03646.x
- By:
- Publication type:
- Article
Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Fosamprenavir: Clinical Pharmacokinetics and Drug Interactions of the Amprenavir Prodrug.
- Published in:
- Clinical Pharmacokinetics, 2006, v. 45, n. 2, p. 137, doi. 10.2165/00003088-200645020-00002
- By:
- Publication type:
- Article
Population pharmacokinetic modeling and simulation of amprenavir following fosamprenavir/ritonavir administration for dose optimization in HIV infected pediatric patients.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 2, p. 206, doi. 10.1002/jcph.205
- By:
- Publication type:
- Article
Clinical Pharmacokinetics, Platelet Response, and Safety of Eltrombopag at Supratherapeutic Doses of up to 200 mg Once Daily in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 301, doi. 10.1177/0091270010368677
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Fosamprenavir-Ritonavir in Opioid-Dependent Subjects.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 7, p. 863, doi. 10.1592/phco.28.7.863
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid-Dependent Subjects.
- Published in:
- Pharmacotherapy, 2004, v. 24, n. 9, p. 1110, doi. 10.1592/phco.24.13.1110.38091
- By:
- Publication type:
- Article
A 42-Week Open-Label Study to Assess the Pharmacokinetics, Antiretroviral Activity, and Safety of Amprenavir or Amprenavir plus Ritonavir in Combination with Abacavir and Lamivudine for Treatment of HIV-Infected Patients.
- Published in:
- Clinical Infectious Diseases, 2004, v. 39, n. 4, p. 591, doi. 10.1086/422452
- By:
- Publication type:
- Article